TD Asset Management Inc bought a new position in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 92,548 shares of the company's stock, valued at approximately $2,306,000. TD Asset Management Inc owned approximately 0.18% of Kestra Medical Technologies as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also added to or reduced their stakes in the company. Brown Advisory Inc. purchased a new stake in Kestra Medical Technologies in the first quarter valued at approximately $13,716,000. Jennison Associates LLC purchased a new stake in Kestra Medical Technologies in the first quarter valued at approximately $1,869,000. Finally, Caas Capital Management LP purchased a new stake in Kestra Medical Technologies in the first quarter valued at approximately $1,470,000.
Analysts Set New Price Targets
A number of equities research analysts recently commented on KMTS shares. Wells Fargo & Company dropped their target price on Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating on the stock in a research report on Thursday, July 17th. The Goldman Sachs Group lowered their price objective on Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 16th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $27.33.
Check Out Our Latest Research Report on Kestra Medical Technologies
Kestra Medical Technologies Stock Performance
Kestra Medical Technologies stock traded down $1.22 during midday trading on Wednesday, reaching $14.64. 101,552 shares of the stock traded hands, compared to its average volume of 282,865. The business has a 50-day simple moving average of $17.25. Kestra Medical Technologies, Ltd. has a 12-month low of $13.25 and a 12-month high of $26.15. The company has a debt-to-equity ratio of 0.20, a current ratio of 6.72 and a quick ratio of 6.72.
About Kestra Medical Technologies
(
Free Report)
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Further Reading
Before you consider Kestra Medical Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kestra Medical Technologies wasn't on the list.
While Kestra Medical Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access